Compliance and optimisation of oral antidiabetic therapy: A longitudinal study;Observance et optimisation du traitement antidiabétique oral: Étude longitudinale

Presse Medicale

Volumn 33, Issue 3, 2004, Pages 156-160

  Guillausseau, Pierre Jean ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLICLAZIDE; HEMOGLOBIN A1C; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED RELEASE FORMULATION; DRUG USE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE;

EID: 1242269410     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98512-0     Document Type: Article

References (10)

1. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, Poggi L Use of electronic pill boxes to assess risk of poor treatment compliance, Results of a large-scale trial. Am J Hypertens 1999; 12: 374-80
2. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dose frequency on patient compliance. Diabetes Care 1997; 20: 1512-17
3. Donnan PT, Mac Donald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 2002; 19: 279-84
4. Schectman JM, Nadkarni MM, Voss JD, The association between diabetes metabolic control and drug adherence in an indigent population, Diabetes Care 2002; 25: 1015-21
5. Guillausseau PJ. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. Diabetes Metab 2003; 29: 79-82
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53
7. Dezii CM, Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J 2002; 95: 68-71
8. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003; 26: 1408-12
9. Weill A Ricordeau P, Vallier N, Bourrel R, Fender P, Allemand H. Les modalités de suivi des diabétiques non insulino traités en France métropolitaine durant l'année 1998. Diabetes Metab 2000, 26 (suppl 6):49-54
10. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. Scientific review. JAMA 2002; 287; 360-72